Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

Unlocking the full potential of healthcare company partnerships

The most successful partnerships overcome both cultural and organisational divides

- PMLiVE

Novo Nordisk presents new findings on semaglutide in Alzheimer’s disease

While the trials did not meet their primary endpoints, they highlighted important biomarker findings

- PMLiVE

Avalere Health appoints Sarah Hall as President of US Marketing

Hall was previously President of FCB Health New York

- PMLiVE

Global regulatory standards

The US, EU and UK operate under different systems, with distinct expectations for clinical evidence, timelines and commercial readiness

- PMLiVE

Exhibition Trends 2026: What Pharma Exhibitors Need to Know Now

Exhibitions remain one of the most powerful ways for pharmaceutical and life sciences organisations to connect, educate and build trust. Whether you're launching innovations, strengthening partnerships or showcasing research, the...

Apex Events and Exhibitions

- PMLiVE

Pfizer’s Hympavzi significantly reduces bleeds in haemophilia patients

Over 800,000 people worldwide live with haemophilia

- PMLiVE

Gilead’s Yescarta shows benefits for patients with large B-cell lymphoma

This is the most common type of non-Hodgkin lymphoma worldwide

- PMLiVE

Patient insight: human vs AIHCPS

If we’re using AI to inform healthcare decisions, ethical guard rails are essential

EcoVadis silver medal with Amiculum's results

Amiculum earns EcoVadis silver medal for the 3rd year running

We’re proud to announce that we have once again strengthened our commitment to sustainability! Our 2025 EcoVadis reassessment has resulted in a score of 75/100, allowing us to maintain our...

Amiculum

- PMLiVE

Bridging the affordability gap

How pharma can rebuild competitiveness from the factory floor

- PMLiVE

Vandria announces positive phase 1 data for Alzheimer’s treatment

Trial data showed that VNA-318 has the ability to penetrate the brain

- PMLiVE

NRG Therapeutics appoints Paul Thompson as Chief Development Officer

Thompson previously held senior roles at Mission Therapeutics and GSK

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links